Hobart Private Capital’s Sanofi SNY Stock Holding History

Hobart Private Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,362	Closed	-$450K	–	169
2018 Q4	$450K	Buy	+10,362	New	+$457K	0.39%	72
2018 Q3	–	Sell	-15,439	Closed	-$618K	–	153
2018 Q2	$618K	Sell	15,439 -1,265	-8%	-$49.8K	0.5%	61
2018 Q1	$669K	Sell	16,704 -94	-0.6%	-$3.91K	0.59%	56
2017 Q4	$722K	Buy	+16,798	New	+$775K	0.64%	51

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hobart Private Capital's SNY Position: Q1 2019 in Review

Hobart Private Capital sold out of Sanofi (SNY) in Q1 2019, closing a stake of 10,362 shares — an estimated $450K sold.

Hobart Private Capital first reported a position in SNY in Q4 2017 and held it in 4 quarters. The position peaked at $722K in Q4 2017. 489 funds tracked by Wall St. Rank hold SNY as of Q1 2019.

Hobart Private Capital reported no remaining Sanofi position as of Q1 2019 after selling out during the quarter.
Hobart Private Capital sold 10,362 Sanofi shares in Q1 2019, an estimated $450K.
Hobart Private Capital first reported a position in Sanofi in Q4 2017 and held it in 4 quarters.
Hobart Private Capital's Sanofi position peaked at $722K in Q4 2017.
489 funds tracked by Wall St. Rank held Sanofi as of Q1 2019.

Based on Hobart Private Capital's 13F filing for Q1 2019, filed 11 Mar 2024.